Get the Stockscreener App
1.0399
2.96%
0.0299
Xortx Therapeutics Inc Stock (XRTX) Forecast
The Xortx Therapeutics Inc (XRTX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.4514, representing a -56.59% decrease from the current price of $1.0399. The highest analyst price target is $0.7649, and the lowest is $0.1379.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month XRTX Price Target
Average 0.436
(-58.07% Downside)
Is Xortx Therapeutics Inc (XRTX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 55.47 | Neutral |
| STOCH(9,6) | 60.62 | Neutral |
| STOCHRSI(14) | 97.82 | Sell |
| MACD(12,26) | 0.00804 | Buy |
| ADX(14) | 34.25 | Buy |
| William %R | -21.88 | Neutral |
| CCI(14) | 58.28 | Neutral |
Buy: 2
Sell: 1
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.9653
Buy
|
0.9787
Buy
|
| MA20 |
0.9522
Buy
|
0.9661
Buy
|
| MA50 |
0.9774
Buy
|
1.0056
Buy
|
| MA100 |
1.1252
Sell
|
1.154
Sell
|
| MA200 |
1.4598
Sell
|
1.5182
Sell
|
Buy: 6
Sell: 4
Neutral: 0
Summary: Buy
According to our latest analysis, XRTX could be considered a Potential Buy, with 17 technical analysis indicators signaling 8 Buy signals, 5 signaling Sell signals and 4 Neutral signals. This might be a good time to open fresh positions on XRTX, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 55.47 indicates that XRTX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 60.62 indicates that XRTX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 97.82 indicates that XRTX is oversold. This suggests that XRTX price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 34.25 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 58.28 indicates that XRTX is still overbought but not to an extreme extent.
Long-term XRTX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Xortx Therapeutics Inc financial reports and earnings history, Xortx Therapeutics Inc (XRTX) stock could reach $2.1492 by 2030, $5.8434 by 2040 and $4.8555 by 2050. See the projected annual prices until 2050 of the Xortx Therapeutics Inc stock below:
- Xortx Therapeutics Inc (XRTX) is expected to reach an average price of $3.3897 in 2035, with a high prediction of $3.3875 and a low estimate of $3.3297. This indicates an $225.97% rise from the last recorded price of $1.0399.
- Xortx Therapeutics Inc (XRTX) stock is projected to chart a bullish course in 2040, with an average price target of $5.9064, representing an $467.97% surge from its current level. The forecast ranges from a conservative $5.9191 to a sky-high $5.8434.
- Our analysts predict Xortx Therapeutics Inc (XRTX) to jump 696.92% by 2045, soaring from $8.1189 to an average price of $8.2872, potentially reaching $8.055. While $8.1189 is the low estimate, the potential upside is significant.
- Xortx Therapeutics Inc (XRTX) stock is expected to climb by 2050, reaching an average of $3.5991, a $246.10% jump from its current level. However, a wide range of estimates exists, with high and low targets of $4.8555 and $3.846, respectively, highlighting the market's uncertainty.
Xortx Therapeutics Inc Stock (XRTX) Year by Year Forecast
Xortx Therapeutics Inc Stock (XRTX) Price Forecast for 2025
Xortx Therapeutics Inc Stock (XRTX) is expected to reach an average price of $0.53 in 2025, with a high prediction of $1.037 and a low estimate of $0.0231. This indicates an -49.03% fall from the last recorded price of $1.0399.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| April, 2025 | $0.1538 | $0.1379 | $0.7649 | -85.21% |
| May, 2025 | $0.1442 | $0.1072 | $0.2268 | -86.13% |
| June, 2025 | $0.2973 | $0.3412 | $0.2973 | -71.41% |
| July, 2025 | $0.2573 | $0.3173 | $0.2393 | -75.25% |
| August, 2025 | $0.3754 | $0.2543 | $0.2665 | -63.90% |
| September, 2025 | $0.3484 | $0.372 | $0.2071 | -66.49% |
| October, 2025 | $0.4878 | $0.5045 | $0.4705 | -53.10% |
| November, 2025 | $0.5426 | $0.533 | $0.4835 | -47.83% |
| December, 2025 | $0.3331 | $0.5514 | $0.5676 | -67.97% |
Xortx Therapeutics Inc Stock (XRTX) Price Forecast for 2026
The predicted value for Xortx Therapeutics Inc (XRTX) in 2026 is set at an average of $1.4898. Estimates vary from a peak of $2.6437 to a trough of $0.3359, indicating an +43.27% surge from the present price of $1.0399.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.3443 | $0.4156 | $0.3206 | -66.89% |
| February, 2026 | $0.3341 | $0.3576 | $0.3051 | -67.87% |
| March, 2026 | $0.3767 | $0.3888 | $0.3288 | -63.78% |
| April, 2026 | $0.3509 | $0.3359 | $0.3428 | -66.25% |
| May, 2026 | $0.3488 | $0.4174 | $0.3819 | -66.46% |
| June, 2026 | $0.3269 | $0.3509 | $0.3069 | -68.56% |
| July, 2026 | $0.333 | $0.4209 | $0.585 | -67.98% |
| August, 2026 | $0.6501 | $0.671 | $0.626 | -37.49% |
| September, 2026 | $1.4649 | $0.6936 | $2.2329 | +40.87% |
| October, 2026 | $1.8268 | $1.0438 | $2.5067 | +75.67% |
| November, 2026 | $1.4588 | $1.1829 | $1.9527 | +40.28% |
| December, 2026 | $2.1337 | $1.2818 | $2.6437 | +105.18% |
Xortx Therapeutics Inc Stock (XRTX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Xortx Therapeutics Inc (XRTX) is $3.0633, with a high forecast of $6.0997 and a low forecast of $0.027. This indicates an +194.58% increase from the last price of $1.0399.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $3.5557 | $1.9667 | $6.0997 | +241.92% |
| February, 2027 | $2.1148 | $1.9476 | $3.5586 | +103.37% |
| March, 2027 | $0.119 | $0.027 | $3.253 | -88.56% |
| April, 2027 | $0.6171 | $0.1051 | $0.5249 | -40.65% |
| May, 2027 | $0.5332 | $0.7391 | $0.5192 | -48.72% |
| June, 2027 | $1.0134 | $0.6773 | $0.9534 | -2.55% |
| July, 2027 | $1.0595 | $0.9714 | $1.0495 | +1.88% |
| August, 2027 | $1.2356 | $1.1815 | $1.1199 | +18.82% |
| September, 2027 | $0.5907 | $0.5976 | $0.5076 | -43.20% |
| October, 2027 | $0.9318 | $0.7097 | $0.6638 | -10.39% |
| November, 2027 | $1.1479 | $1.1258 | $1.0679 | +10.39% |
| December, 2027 | $1.048 | $1.098 | $1.028 | +0.78% |
Xortx Therapeutics Inc Stock (XRTX) Price Forecast for 2028
In 2028, Xortx Therapeutics Inc (XRTX) is projected to reach an average price of $1.2907, with a high projection of $1.6352 and a low estimate of $0.9462. This indicates an +24.12% rise from the last price of $1.0399.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.0141 | $1.1041 | $0.9021 | -2.48% |
| February, 2028 | $0.9002 | $0.9462 | $0.8383 | -13.43% |
| March, 2028 | $1.1104 | $1.0123 | $0.9804 | +6.78% |
| April, 2028 | $1.3067 | $1.2644 | $1.2965 | +25.65% |
| May, 2028 | $1.4466 | $1.4616 | $1.4395 | +39.11% |
| June, 2028 | $1.3359 | $1.3787 | $1.2931 | +28.47% |
| July, 2028 | $1.4687 | $1.4721 | $1.3819 | +41.24% |
| August, 2028 | $1.5958 | $1.4928 | $1.5549 | +53.46% |
| September, 2028 | $1.5764 | $1.603 | $1.559 | +51.59% |
| October, 2028 | $1.6611 | $1.6189 | $1.6282 | +59.73% |
| November, 2028 | $1.4708 | $1.5013 | $1.6352 | +41.44% |
| December, 2028 | $1.3485 | $1.4115 | $1.3692 | +29.67% |
Xortx Therapeutics Inc Stock (XRTX) Price Forecast for 2029
The 2029 price forecast for Xortx Therapeutics Inc Stock (XRTX) is $2.6535 on average, with a high prediction of $5.1994 and a low estimate of $0.1077. This represents an +155.17% increase from the previous price of $1.0399.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.3961 | $1.3953 | $1.3575 | +34.26% |
| February, 2029 | $1.3385 | $1.4253 | $1.3656 | +28.72% |
| March, 2029 | $1.3997 | $1.3497 | $1.3697 | +34.60% |
| April, 2029 | $1.2958 | $1.3438 | $1.3838 | +24.61% |
| May, 2029 | $1.68 | $1.4018 | $1.356 | +61.55% |
| June, 2029 | $1.6291 | $1.6621 | $1.5921 | +56.66% |
| July, 2029 | $1.0118 | $0.5819 | $1.5573 | -2.70% |
| August, 2029 | $0.4117 | $0.1578 | $1.1978 | -60.41% |
| September, 2029 | $0.4156 | $0.1077 | $1.5735 | -60.03% |
| October, 2029 | $0.4055 | $0.2916 | $0.7208 | -61.01% |
| November, 2029 | $2.9694 | $0.4514 | $5.1994 | +185.54% |
| December, 2029 | $1.9233 | $1.2933 | $4.0153 | +84.95% |
Xortx Therapeutics Inc Stock (XRTX) Price Forecast for 2030
Xortx Therapeutics Inc Stock (XRTX) is expected to reach an average price of $1.562 in 2030, with a high forecast of $2.3727 and a low forecast of $0.7513. This signifies an +50.20% surge from the last price of $1.0399.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.4503 | $0.7513 | $2.1492 | +39.46% |
| February, 2030 | $1.5686 | $1.2864 | $1.9345 | +50.84% |
| March, 2030 | $1.9028 | $1.7997 | $1.6428 | +82.98% |
| April, 2030 | $1.8869 | $1.9659 | $1.8138 | +81.45% |
| May, 2030 | $2.1721 | $2.188 | $2.23 | +108.88% |
| June, 2030 | $2.3863 | $2.3532 | $2.3142 | +129.47% |
| July, 2030 | $1.8115 | $1.8415 | $2.3727 | +74.20% |
| August, 2030 | $2.3956 | $1.8425 | $1.8956 | +130.37% |
| September, 2030 | $2.3098 | $2.3277 | $2.1398 | +122.12% |
| October, 2030 | $2.385 | $2.3579 | $2.2819 | +129.35% |
| November, 2030 | $1.8791 | $2.2971 | $2.2271 | +80.70% |
| December, 2030 | $2.0933 | $2.1633 | $2.0612 | +101.30% |
0.37%
1.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):